Department of Neurosurgery, China Medical University Hospital, North District, No.2, Yude Road, Taichung City, 404472, Taiwan, Republic of China.
China Medical University, Taichung City, Taiwan, Republic of China.
Childs Nerv Syst. 2022 Aug;38(8):1567-1572. doi: 10.1007/s00381-022-05542-3. Epub 2022 May 5.
This study aims to evaluate the infection rates and catheterization duration of applying antibiotic-impregnated external ventricular drain (EVD) for the treatment of post-hemorrhagic hydrocephalus (PHH) in low birth weight infants (LBWI).
This retrospective cohort study included 13 preterm LBWI with PHH. Data were collected from the patient's medical charts and included gender, gestational age, birth weight, intraventricular hemorrhage grade, ventriculostomy-associated infection (VAI), and the duration of catheterization. All patients were followed up for at least 6 months after EVD surgery.
The mean gestational age at birth was 27 ± 2.5 weeks, and the mean birth weight was 907 ± 220 g. Among all patients with IVH, two (6.7%) had grade 2 IVH, five (38.5%) had grade 3 IVH, and six (46.2%) had grade 4 IVH. EVD surgery was conducted once for six patients, twice for five patients, and three times for two patients. One patient (7.7%) had VAI post-EVD surgery at 14 days. Three patients (23%) expired due to sepsis, shock, and chylous ascites. Seven patients (53.8%) had hydrocephalus and needed a ventriculoperitoneal shunt over the following course. The longest EVD catheterization period was 57 days without sustained VAI.
Antibiotic-impregnated EVD has a similar infection rate with the ventricular access device and ventriculosubgaleal shunt. The risk of VAI was not increased even with the EVD catheterization day approaching 2 months. Our study supports the evidence that antibiotic-impregnated EVD is safe and effective for the management of PHH in LBWI. However, this research has a small sample sized and a retrospective design.
本研究旨在评估在极低出生体重儿(LBWI)中应用抗生素浸渍的外部脑室引流(EVD)治疗出血后脑积水(PHH)的感染率和置管时间。
本回顾性队列研究纳入了 13 例患有 PHH 的早产儿 LBWI。从患者的病历中收集数据,包括性别、胎龄、出生体重、脑室内出血程度、脑室引流相关感染(VAI)和导管留置时间。所有患者在 EVD 手术后至少随访 6 个月。
出生时的平均胎龄为 27±2.5 周,平均出生体重为 907±220g。所有 IVH 患者中,2 例(6.7%)为 2 级 IVH,5 例(38.5%)为 3 级 IVH,6 例(46.2%)为 4 级 IVH。EVD 手术 1 次的有 6 例,2 次的有 5 例,3 次的有 2 例。1 例(7.7%)患者在 EVD 手术后 14 天发生 VAI。3 例(23%)患者因败血症、休克和乳糜性腹水死亡。7 例(53.8%)患者有脑积水,在随后的治疗过程中需要脑室-腹腔分流术。最长的 EVD 导管留置时间为 57 天,没有持续的 VAI。
抗生素浸渍的 EVD 与脑室接入装置和脑室下腔分流术具有相似的感染率。即使 EVD 导管留置时间接近 2 个月,VAI 的风险也没有增加。我们的研究支持了抗生素浸渍的 EVD 是安全有效的,可用于治疗 LBWI 的 PHH 的证据。然而,这项研究的样本量较小,且为回顾性设计。